the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)
Clinical trial NCT05527704 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05527704
- Sponsor
- Medical University of Warsaw
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-31
- Primary completion
- 2025-11-30
- Enrollment
- 608
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.